Search PubMed⌕ Search

PubMed · 7859613

Exercise therapy in Japan.

Abstract

The purpose of this report is to outline the exercise therapy of diabetes mellitus that has been administered in Japan during the past 10 years, with special emphasis on the results of studies on metabolic effects as well as on practical aspects of exercise therapy. The studies on the response to exercise clarified neuroendocrine mechanisms involved in the regulation of carbohydrate and fat metabolism in exercise and provided a basis for the indication of exercise therapy in view of the pre-existing metabolic abnormalities. Concerning the training effects, changes of insulin sensitivity have been chiefly studied in relation to metabolic improvement by physical training using the insulin clamp method. The improvement of glucose and lipid metabolism obtained during the training program, consisting of fast walking or jogging corresponding to 40-60% of predictive VO2 max for 30-60 min daily, was suggested to be related to improved insulin sensitivity in patients with NIDDM. Intensive studies have been made on exercise programs, and medical checks and guidelines for exercise prescription have been provided. Aerobic exercises with stretching and low-level callisthenics are recommended, and the usefulness of a multi-stage exercise loading test and the necessity of self-monitoring of blood glucose are stressed for the successful management of exercise therapy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S Fujii. 1994. Exercise therapy in Japan.. https://doi.org/10.1016/0168-8227(94)90256-9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.

The purification of animal insulin preparations and the use of human recombinant insulin have markedly reduced the incidence but not completely suppressed the occurrence of insulin allergy manifestations. Advances in technologies concerning the mode of delivery of insulin, i.e. continuous subcutaneous insulin infusion (CSII), and the use of insulin analogues, resulting from the alteration in the amino acid sequence of the native insulin molecule, may influence the immunogenicity and antigenicity of native insulin. Instead of increasing allergy reactions, CSII has been reported to represent a successful alternative treatment in diabetic patients presenting local or generalized allergy to insulin or other components (zinc, protamine) of conventional treatment. Most recent reports concern CSII-treated patients using short-acting insulin analogues (essentially insulin lispro), although the precise role of these insulin analogues remains unclear as allergy to them has also been described. Finally, data on antigenicity and immunogenicity of long-acting insulin analogues (glargine, detemir), which may mimic the basal insulin delivery with CSII, remain scarce at present.

Diabetes Mellitus↗

Effects of glucose homeostasis on protein metabolism in patients with advanced chronic kidney disease.

Insulin deficiency is known to be associated with a state of increased muscle protein breakdown; this process is mediated by the ubiquitin-proteasome pathway. Convincing in vitro data are further supported by extensive studies in humans with insulin deprivation and are further substantiated by reversal of muscle protein breakdown with insulin treatment. In patients with end-stage renal disease (ESRD) and diabetes mellitus (DM), muscle protein breakdown is enhanced in both acute and chronic conditions. Recent data also point to the potential protein catabolic effects of insulin resistance combined with insulin deficiency. Because ESRD is associated with a state of insulin resistance, uremic muscle wasting may also be mediated by this pathway.

Diabetes Mellitus↗